Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Oral Antibiotics by Class
5.1 Beta Lactam And Beta Lactamase Inhibitors
5.1.1 Market Size and Forecast
5.2 Macrolides
5.2.1 Market Size and Forecast
5.3 Quinolones
5.3.1 Market Size and Forecast
5.4 Others
5.4.1 Market Size and Forecast

Part 6. Global Market for Oral Antibiotics by Application
6.1 Community-Acquired Respiratory Tract Infections (Cartis)
6.1.1 Market Size and Forecast
6.2 Dental
6.2.1 Market Size and Forecast
6.3 Urinary Tract Infections (Utis)
6.3.1 Market Size and Forecast
6.4 Others
6.4.1 Market Size and Forecast

Part 7. Global Market for Oral Antibiotics by Drug Origin
7.1 Natural
7.1.1 Market Size and Forecast
7.2 Semisynthetic
7.2.1 Market Size and Forecast
7.3 Synthetic
7.3.1 Market Size and Forecast

Part 8. Global Market for Oral Antibiotics by Drug Type
8.1 Branded
8.1.1 Market Size and Forecast
8.2 Generics
8.2.1 Market Size and Forecast

Part 9. Key Competitor Profiles
9.1 Abbott Laboratories
9.2 Allergan PLC
9.3 GlaxoSmithKline plc (GSK)
9.4 Merck & Co.
9.5 Mylan N.V.
9.6 Novartis International AG
9.7 Pfizer Inc.
9.8 Roche Holding AG
9.9 Sanofi S.A.
*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY